Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: Analysis of 48 cases

Cancer

Volumn 95, Issue 3, 2002, Pages 588-595

  Ando, Eiji ^a   Tanaka, Masatoshi ^a   Yamashita, Fumihiko ^b   Kuromatsu, Ryoko ^a   Yutani, Shigeru ^a   Fukumori, Kazuta ^a   Sumie, Shuji ^a   Yano, Yoichi ^b   Okuda, Koji ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Saga Social Insurance Hospital   (Japan)

Author keywords

Biochemical modulation; Cytoreduction; Hepatic arterial infusion chemotherapy (HAIC); Hepatocellular carcinoma; Prognosis; Tumor thrombosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; FEMALE; HEPATIC ARTERY; HUMAN; IMPLANTABLE PORT SYSTEM; JAPAN; LIVER CELL CARCINOMA; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR THROMBUS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUKOPENIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NAUSEA; PEPTIC ULCER; PORTAL VEIN; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0036682065     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10694     Document Type: Article

References (48)

1. Rising incidence of hepatocellular carcinoma in United States
2. Morbidity and mortality in compensated cirrhosis type C
3. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography: A study in 51 patients
4. CT diagnosis of early hepatocellular carcinoma: Sensitivity, findings, and CT-pathologic correlation
5. Hepatocellular carcinoma with venous invasion. Sonographic angiographic correlation
6. Portal vein involvement in hepatocellular carcinoma: Dynamic CT features
7. Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma
8. Demonstration of growing casts of hepatocellular carcinoma in the portal vein by celiac angiography: The thread and streaks sign
9. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years
10. Liver transplantation versus resection for hepatocellular carcinoma in cirrhosis
11. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment
12. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma
13. Microwave coagulation therapy for hepatocellular carcinoma
14. Hepatocellular carcinoma: Comparison of efficacy between percutaneous ethanol instillation and radiofrequency
15. Percutaneous ethanol injection therapy for treatment of hepatocellular carcinoma
16. Percutaneous ethanol injection of portal thrombosis in hepatocellular carcinoma: A new possible treatment
17. Transcatheter oily chemoembolization of hepatocellular carcinoma
18. Natural history of hepatocellular carcinoma and prognosis in relation to treatment - Study of 850 patients
19. Hepatocellular carcinoma with portal thrombus: Analysis of factors determining prognosis
20. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
21. Natural history of primary and secondary tumors of the liver
22. Treatment of hepatocellular carcinoma
23. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
24. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
25. Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: Effect of hepatitis B and C viral infection on drug toxicity and patient survival
26. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin, and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma
27. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma
28. Phase II study of spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: Interim analysis
29. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis
30. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein
31. Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus
32. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma
33. Reporting results of cancer treatment
34. Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients
35. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy
36. Nonparametric estimation from incomplete observation
37. Surgery and portal hypertension
38. Regression models and life-tables
39. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy
40. The blood supply of neoplasms in the liver
41. Clinical pharmacology of hepatic arterial chemotherapy
42. Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced hepatocellular carcinoma
43. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil
44. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
45. 120 Hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer
46. Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma